During their Sunday meeting at State House Entebbe, President Museveni praised Dr. Matthias Magoola for obtaining a U.S. patent on cancer treatment. The president promised government backing to help Ugandan vaccines reach global markets. He stressed the need to pass new drug legislation that would allow Uganda's regulatory agency to meet international standards for approving locally made vaccines.
The U.S. Patent Office recently published Dr. Magoola's patent for cancer therapy using guided RNA with CRISPR-Cas9 gene editing. His method targets cancer mutations but prevents cells from repairing damaged genes, which destroys cancer cells without harming healthy tissue. Dr. Magoola said this offers new hope for treating all cancers without harsh side effects.
His company, Dei Biopharma, has filed over 100 patents for treatments, including HIV, Alzheimer's, malaria, diabetes, and tuberculosis. The firm also created a universal vaccine for foot and mouth disease, which was accepted for patent in January. Experts say Uganda needs more than political support—the country must implement policies, invest in energy, and fund scientists to succeed globally.
The U.S. Patent Office recently published Dr. Magoola's patent for cancer therapy using guided RNA with CRISPR-Cas9 gene editing. His method targets cancer mutations but prevents cells from repairing damaged genes, which destroys cancer cells without harming healthy tissue. Dr. Magoola said this offers new hope for treating all cancers without harsh side effects.
His company, Dei Biopharma, has filed over 100 patents for treatments, including HIV, Alzheimer's, malaria, diabetes, and tuberculosis. The firm also created a universal vaccine for foot and mouth disease, which was accepted for patent in January. Experts say Uganda needs more than political support—the country must implement policies, invest in energy, and fund scientists to succeed globally.
